FGF 1 Human

Fibroblast Growth Factor-Acidic Human Recombinant
Shipped with Ice Packs
In Stock

Description

Structure and Synthesis

  • Gene: FGF1 (chromosome 5q31.3) encodes the FGF-1 precursor, processed into a mature 141-amino-acid protein .

  • Secretion: Lacks a classical signal peptide; secreted via a non-canonical pathway involving S100A13, synaptotagmin-1 (SYT1), and Cu²⁺-dependent dimerization .

  • Stability: Heparin binding enhances stability and facilitates FGFR activation .

PropertyDetails
Molecular Weight16–17 kDa (non-glycosylated)
IsoformsTruncated antagonist isoform (40% N-terminal) identified
Species Crossreactivity92%–96% amino acid identity with bovine, mouse, porcine, and rat FGF-1

Signaling Pathways

FGF-1 binds all four FGFR isoforms (FGFR1–4) and activates:

  • MAPK/ERK: Promotes proliferation and survival .

  • PI3K/AKT: Enhances cell migration and metabolic regulation .

  • Nuclear Activity: Enters the nucleus via an NLS to regulate gene expression (e.g., VEGF, antioxidant enzymes) .

Key Roles in Physiology

  • Angiogenesis: Stimulates endothelial cell proliferation and blood vessel formation .

  • Neuroprotection: Restores dopamine neurons in Parkinson’s disease models .

  • Metabolism: Reverses hyperglycemia in diabetic mice via insulin sensitization .

  • Antioxidant Defense: Upregulates glutathione peroxidase (GPx) in retinal cells under high glucose .

Preclinical and Clinical Trials

  • Parkinson’s Disease: Intranasal FGF-1 improved motor function by 18%–82% in a Phase I trial (NCT data pending), with no adverse events reported .

  • Retinal Disorders: Mitigated oxidative stress and apoptosis in diabetic retinopathy models .

  • Ischemia: Reduced infarct size in cardiac and cerebral ischemia models .

ConditionFindingsReferences
Type 2 DiabetesSingle FGF-1 injection normalized blood glucose for >48 hours in mice
Spinal Cord InjuryEnhanced neuronal survival and functional recovery in primate models
CancerOverexpressed in ovarian/prostate tumors; promotes angiogenesis/metastasis

Key Interactions

  • Intracellular Partners: CK2, FIBP, LRRC59, and mortalin modulate nuclear signaling .

  • Extracellular Matrix: Heparan sulfate proteoglycans sequester FGF-1 for sustained release .

Challenges and Future Directions

  • Short Half-Life: Rapid degradation in vivo necessitates heparin co-administration or engineered analogs .

  • Dual Roles in Cancer: Pro-angiogenic effects may exacerbate tumor growth, requiring targeted delivery .

  • Immune Modulation: Enhances IL-2 production in T cells via NF-κB, suggesting applications in immunotherapy .

Product Specs

Introduction
Acidic fibroblast growth factor (aFGF or FGF-1) is a member of the fibroblast growth factor (FGF) family. FGFs are involved in various biological processes, including embryonic development, cell growth, tissue repair, and angiogenesis. aFGF plays a role in endothelial cell migration and proliferation. It acts as a mitogen for various cell types, suggesting involvement in organogenesis. Multiple isoforms of aFGF exist due to alternative splicing. Heparin-binding growth factors, including aFGF, exhibit angiogenic properties and potent mitogenic activity. The tissue distribution and concentration of these growth factors can differ.
Description
Recombinant Human Fibroblast Growth Factor-acidic (FGF-1) is produced in E. coli. This non-glycosylated polypeptide chain consists of 140 amino acids, resulting in a molecular weight of approximately 15.8 kDa. The purification process involves proprietary chromatographic techniques.
Physical Appearance
White, sterile-filtered lyophilized powder.
Formulation
The protein was lyophilized from a sterile solution containing PBS at pH 7.4 and a concentration of 1 mg/mL.
Solubility
To reconstitute the lyophilized Fibroblast Growth Factor-acidic, dissolve in sterile 18 MΩ-cm H2O at 4°C to a concentration of 0.1-0.25 mg/mL. Let the solution sit undisturbed for 5 minutes at 4°C, then centrifuge briefly to remove any insoluble particles.
Stability
Lyophilized Fibroblast Growth Factor-1 remains stable at room temperature for up to 3 weeks. For long-term storage, store desiccated below -18°C. Reconstituted FGF-a should be stored at 4°C for 2-7 days. For extended storage after reconstitution, freeze aliquots below -18°C. Avoid repeated freeze-thaw cycles.
Purity
Purity is determined using the following methods, with a result of greater than 95%: (a) Reverse-phase high-performance liquid chromatography (RP-HPLC) analysis. (b) Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis.
Biological Activity
The half-maximal effective concentration (ED₅₀) is determined by measuring dose-dependent proliferation of mouse BALB/c 3T3 cells. It is less than 0.5 ng/mL, corresponding to a specific activity greater than 2,000,000 IU/mg.
Synonyms
HBGF-1, ECGF-beta, FIBP, FGFIBP, FIBP-1, ECGF, ECGFA, GLIO703, FGF1, FGF-a.
Source
Escherichia Coli.
Amino Acid Sequence
MFNLPPGNYK KPKLLYCSNG GHFLRILPDG TVDGTRDRSD QHIQLQLSAE SVGEVYIKST ETGQYLAMDT DGLLYGSQTP NEECLFLERL EENHYNTYIS KKHAEKNWFV GLKKNGSCKR GPRTHYGQKA ILFLPLPVSS D.

Product Science Overview

Structure and Characteristics

FGF-acidic is a single-chain polypeptide consisting of 140 amino acids and has a molecular weight of approximately 15.8 kDa . It is produced in a non-glycosylated form in Escherichia coli (E. coli) and is purified using proprietary chromatographic techniques . The protein is known for its ability to bind heparin, which is essential for its interaction with fibroblast growth factor receptors (FGFRs) .

Biological Functions

FGF-acidic is a potent activator of DNA synthesis, cell proliferation, and chemotaxis . It plays a crucial role in various physiological processes, including:

  • Development: FGF-acidic is involved in the development of multiple tissues and organs. It is highly expressed in the central and peripheral nervous systems .
  • Regeneration: The protein promotes tissue repair and regeneration by stimulating the proliferation of various cell types, including fibroblasts, endothelial cells, and neurons .
  • Angiogenesis: FGF-acidic is a key player in angiogenesis, the formation of new blood vessels, which is vital for wound healing and tissue growth .
Mechanism of Action

FGF-acidic exerts its effects by binding to specific FGFRs on the cell surface. This binding triggers a cascade of intracellular signaling pathways, including the activation of protein kinase C and the inhibition of p53 and proapoptotic signaling . These pathways promote cell survival, proliferation, and differentiation .

Applications

Human recombinant FGF-acidic is widely used in research and therapeutic applications. Some of its notable uses include:

  • Cell Culture: FGF-acidic is used as a growth factor in cell culture media to promote the proliferation of various cell types .
  • Tissue Engineering: The protein is incorporated into biomaterials to enhance tissue regeneration and repair .
  • Neuroscience Research: FGF-acidic is used to study neural development and neuroprotection .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.